MANIPALHOS

Manipal Health Enterprises Limited

Manipal Health Enterprises Limited (MANIPALHOS) financial statements and selected valuation metrics through 30 June 2026.

Healthcare›Healthcare›Healthcare Services›Hospital

manipalhospitals.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹642.40
Market cap
84,500 Cr
Stock P/E
83.3 · FY26
P/B
8.82
ROE (FY26)
10.1%
ROCE (FY26)
10.6%
Operating margin (FY26)
18.7%
Debt / equity (FY26)
1.25
OCF / EBITDA (FY26)
79.6%
OCF / EBITDA (3Y)
78.4%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Manipal Health Enterprises runs Manipal Hospitals, a chain of about 50 private hospitals across India that treats patients for complex conditions such as oncology and orthopaedics; management says it has the country's largest bed capacity, over 13,000 beds (August 2026 call).

Company snapshot

2ndBy market cap

Ranked among 24 companies in Hospital.

What we see

Positives
  • ✓Revenue grew 25% in the latest year — strong top-line momentum.

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricJun 2026
Sales3,091 Cr
Operating expenses (approx.)2,354 Cr
EBITDA737 Cr
OPM %23.8%
Other income75 Cr
Interest293 Cr
Depreciation187 Cr
Profit before tax315 Cr
Tax %22.8%
Net profit243 Cr
EPS (₹)₹1.96

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2024Mar 2025Mar 2026TTM
Sales6,172 Cr8,242 Cr10,336 CrSign in free for the trailing twelve months
Operating expenses (approx.)4,489 Cr6,116 Cr7,725 CrSign in free for the trailing twelve months
EBITDA1,683 Cr2,127 Cr2,611 CrSign in free for the trailing twelve months
OPM %27.3%25.8%25.3%Sign in free for the trailing twelve months
Other income94 Cr121 Cr185 CrSign in free for the trailing twelve months
Interest455 Cr512 Cr864 CrSign in free for the trailing twelve months
Depreciation397 Cr507 Cr680 CrSign in free for the trailing twelve months
Profit before tax745 Cr1,242 Cr1,178 CrSign in free for the trailing twelve months
Tax %28.4%12.9%22.2%Sign in free for the trailing twelve months
Net profit533 Cr1,082 Cr917 CrSign in free for the trailing twelve months
EPS (₹)₹5.27₹9.25₹7.71Sign in free for the trailing twelve months
Dividend payout %———Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2024Mar 2025Mar 2026
Equity capital76 Cr77 Cr236 Cr
Reserves3,940 Cr5,770 Cr8,190 Cr
Borrowings3,944 Cr4,767 Cr10,553 Cr
Other liabilities2,787 Cr3,305 Cr5,512 Cr
Total liabilities10,819 Cr14,072 Cr24,865 Cr
Fixed assets (net)3,750 Cr4,225 Cr5,841 Cr
CWIP42 Cr614 Cr795 Cr
Investments1,121 Cr1,776 Cr2,675 Cr
Inventories103 Cr132 Cr170 Cr
Trade receivables459 Cr637 Cr930 Cr
Cash & bank361 Cr291 Cr299 Cr
Other assets4,983 Cr6,397 Cr14,154 Cr
Total assets10,819 Cr14,072 Cr24,865 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2024Mar 2025Mar 2026
Cash from operating activity1,389 Cr1,570 Cr2,078 Cr
Cash from investing-870 Cr-2,658 Cr-7,037 Cr
Cash from financing-250 Cr904 Cr4,954 Cr
Net cash flow268 Cr-184 Cr-4 Cr
Free cash flow (OCF − Capex)1,062 Cr520 Cr767 Cr

Ratios

MetricMar 2024Mar 2025Mar 2026
ROCE %14.9%16.3%10.6%
ROE %14.5%17.8%10.1%
Debtor days272833
Inventory days666
Days payable675052
Cash conversion cycle-34-16-13
OCF / EBITDA %82.5%73.8%79.6%
OCF / EBITDA % (3 years)——78.4%
Debt / equity0.980.821.25
Current ratio1.241.591.22
Net debt / EBITDA2.132.103.93